These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2585031)

  • 1. Inhibitors and inactivators of beta-lactamase from Mycobacterium fortuitum.
    Fattorini L; Amicosante G; Fiorentino D; Franceschini N; Di Marzio L; Oratore A; Orefici G
    J Chemother; 1989 Oct; 1(5):293-7. PubMed ID: 2585031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of beta-lactamase production to the resistance of mycobacteria to beta-lactam antibiotics.
    Quinting B; Reyrat JM; Monnaie D; Amicosante G; Pelicic V; Gicquel B; Frère JM; Galleni M
    FEBS Lett; 1997 Apr; 406(3):275-8. PubMed ID: 9136901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics.
    Fattorini L; Scardaci G; Jin SH; Amicosante G; Franceschini N; Oratore A; Orefici G
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1760-4. PubMed ID: 1952844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds.
    Galleni M; Franceschini N; Quinting B; Fattorini L; Orefici G; Oratore A; Frère JM; Amicosante G
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1608-14. PubMed ID: 7979294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of beta-lactamases in Mycobacterium fortuitum including a role in beta-lactam resistance and evidence of partial inducibility.
    Nash DR; Wallace RJ; Steingrube VA; Udou T; Steele LC; Forrester GD
    Am Rev Respir Dis; 1986 Dec; 134(6):1276-82. PubMed ID: 3491556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoelectric focusing of beta-lactamases in Mycobacterium fortuitum. Association of a single enzyme pattern with cefoxitin resistance.
    Wallace RJ; Nash DR; Udou T; Steingrube VA; Steele LC; Swenson JM; Silcox VA
    Am Rev Respir Dis; 1985 Nov; 132(5):1093-7. PubMed ID: 3877482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactamase inactivation by mechanism-based reagents.
    Fisher J; Belasco JG; Charnas RL; Khosla S; Knowles JR
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):309-19. PubMed ID: 6109326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-lactamase production and biological characteristics in nitrosoguanidine induced Mycobacterium fortuitum mutants.
    Fattorini L; Fiorentino D; Amicosante G; Franceschini N; Oratore A; Orefici G
    Acta Leprol; 1989; 7 Suppl 1():44-7. PubMed ID: 2504003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
    Prabhakaran K; Harris EB; Randhawa B; Hastings RC
    Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a beta-lactamase from Mycobacterium smegmatis SN2.
    Basu D; Narayankumar DV; Van Beeumen J; Basu J
    Biochem Mol Biol Int; 1997 Oct; 43(3):557-62. PubMed ID: 9352074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview.
    Matagne A; Ghuysen MF; Frère JM
    Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):705-11. PubMed ID: 8240281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action.
    Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA
    mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and characterization of beta-lactamases of mycobacteria and related organisms.
    Kwon HH; Tomioka H; Saito H
    Tuber Lung Dis; 1995 Apr; 76(2):141-8. PubMed ID: 7780097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal and intracellular activity of β-lactams against Mycobacterium abscessus.
    Lefebvre AL; Dubée V; Cortes M; Dorchêne D; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2016 Jun; 71(6):1556-63. PubMed ID: 26929268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
    Dinçer I; Ergin A; Kocagöz T
    Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
    Sawai T; Tsukamoto K
    J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.
    Prabhakaran K; Harris EB; Randhawa B; Adams LB; Williams DL; Hastings RC
    Microbios; 1993; 76(309):251-61. PubMed ID: 8302203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to beta-lactams in Mycobacterium fortuitum.
    Fattorini L; Orefici G; Jin SH; Scardaci G; Amicosante G; Franceschini N; Chopra I
    Antimicrob Agents Chemother; 1992 May; 36(5):1068-72. PubMed ID: 1510395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.